Lead

No safe blood lead level has been established for any population, making lead one of the most clinically significant toxic heavy metals monitored in laboratory settings. Blood lead testing serves as the primary biomarker for pediatric lead poisoning surveillance per CDC’s updated blood lead reference value of 3.5 µg/dL, OSHA-mandated occupational exposure monitoring for workers in construction, battery manufacturing, smelting, and painting industries, and clinical toxicology assessments evaluating neurotoxic, hematologic, renal, and developmental effects associated with both acute and chronic exposure. UTAK’s dedicated single-analyte controls and comprehensive metals panels contain lead in whole blood and urine matrices at multiple concentration levels, supporting ICP-MS and graphite furnace atomic absorption spectrometry methods used in heavy metal testing programs. Stock and custom QC solutions can incorporate related toxic and essential trace elements such as arsenic, cadmium, mercury, chromium, manganese, copper, zinc, and other metals to address your laboratory’s comprehensive heavy metal, pediatric screening, and occupational health testing requirements.